Instrumented spondylodesis in degenerative spondylolisthesis with bioactive glass and autologous bone: A prospective 11-year follow-up

Journal of Spinal Disorders and Techniques

Volumn 24, Issue 7, 2011, Pages 455-461

  Frantzén, Janek ^a   Rantakokko, Juho ^a   Aro, Hannu T ^a   Heinänen, Jyrki ^a   Kajander, Sami ^a   Gullichsen, Eero ^a   Kotilainen, Esa ^a   Lindfors, Nina C ^b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Bioactive glass; bone substitute; spinal fusion; spondylolisthesis

Indexed keywords

BIOACTIVE GLASS S53P4; GLASS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACKACHE; BONE GRAFT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DEGENERATIVE DISEASE; DEGENERATIVE SPONDYLOLISTHESIS; FEMALE; FOLLOW UP; GAIT; HIP PAIN; HUMAN; LOW BACK PAIN; MALE; OSWESTRY DISABILITY INDEX; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADICULAR PAIN; RADIOGRAPHY; SPONDYLODESIS; SPONDYLOLISTHESIS; VISUAL ANALOG SCALE;

AGED; BONE REGENERATION; BONE SUBSTITUTES; BONE TRANSPLANTATION; FEMALE; FOLLOW-UP STUDIES; GLASS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SPINAL FUSION; SPONDYLOLISTHESIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 80053341552     PISSN: 15360652     EISSN: 15392465     Source Type: Journal    
DOI: 10.1097/BSD.0b013e31822a20c6     Document Type: Article

References (23)

1. Booth KC, Bridwell KH, Eisenberg BA, et al. Minimum 5-year results of degenera-tive spondylolisthesis treated with decompression and instrumented posterior fusion. Spine (Phila Pa 1976). 1999;24:1721-27 (Pubitemid 29387929)
2. Fischgrund JS, Mackay M, Herkowitz HN, et al. Volvo Award winner in clinical studies. Degenerative lumbar spondylolisthesis with spinal stenosis: A prospective, randomized study comparing decompressive laminectomy and arthrodesis with and without spinal instrumentation. Spine (Phila Pa 1976). 1997;22:2807-2812 (Pubitemid 28070625)
3. Banwart JC, Asher MA, Hassanein RS. Iliac crest bone graft harvest donor site morbidity: A statisti-cal evaluation. Spine. 1995;20:1055-1060
4. Hench LL. Bioceramics: From concept to clinics. J Am Ceram Soc. 1991;74:1487-1510.
5. Summers BN, Eisenstein SM. Donor site pain from the ilium: A complication of lumbar spine fusion. J Bone Joint Surg (Br). 1989;71:677-680 (Pubitemid 19211233)
6. Andersson O, Karlsson KH. On the bioactivity of bioactive glassceramic materials to bone and muscle. J Non-Cryst Solids. 1991;129:145-151
7. Peltola M, Aitasalo K, SuonpääJ, et al. Bioactive glass S53P4 in frontal sinus obliteration: A long term clinical experience. Head Neck. 2006;28:834-841 (Pubitemid 44320538)
8. Lindfors NC, HeikkiläJT, Koski I, et al. Bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors. J Biomed Mater Res. 2009;90:131-136
9. Andersen T, Videbaek TS, Hansen ES, et al. The positive effect of poster-olateral lumbar spinal fusion is preserved at long-term followup: A RCT with 11 to 13 year follow-up. Eur Spine J. 2008;17:272-280 (Pubitemid 351197878)
10. Pearson A, Blood E, Lurie J, et al. Degenerative spondylolisthesis versus spinal stenosis: Does a slip matter? Comparison of baseline characteristics and outcomes (SPORT). Spine. 2010;35:298-305
11. Lee CS, Hwang CL, Lee SW, et al. Risk factors for adjacent segment disease after lumbar fusion. Eur Spine J. 2009;18:1637-1643
12. Virolainen P, HeikkiläJ, Yli-Urpo A, et al. Histomorphometric and molecular biologic comparison of bioactive glass granules and autogenous bone grafts in augmentation of bone healing. J Biomed Mater Res. 1997;35:9-17 (Pubitemid 27143007)
13. Lindfors NC, Tallroth K, Aho AJ. Bioactive glass as bone-graft substitute for posterior spinal fusion in rabbit. J Biomed Mater Res. 2002;63:237-244 (Pubitemid 34263870)
14. Ilharreborde B, Morel E, Fitoussi F, et al. Bioac-tive glass as a bone substitute for spinal fusion in adolescent idiopathic scoliosis: A comparative study with iliac crest autograft. J Ped Orthop. 2008;28:347-351 (Pubitemid 351440845)
15. Kasai Y, Takegami K, Uchida A. Mixture ratios of local bone to artificial bone in lumbar posterolateral fusion. J Spinal Disord Tech. 2003;16:31-37
16. Chen W-J, Tsai T-T, Chen L-H, et al. The fusion rate of calcium sulfate with local autograft bone compared with autologous iliac bone graft for instrumented short-segment spinal fusion. Spine. 2005;30:2293-2297 (Pubitemid 41504899)
17. Acharya NK, Kumar RJ, Varma HK, et al. Hydroxyapatitebioactive glass ceramic composite as stand-alone graft substitute for posterolateral fusion of lumbar spine: A prospective, matched, and controlled study. J Spinal Disord Tech. 2008;21:106-111 (Pubitemid 351507599)
18. Briem D, Linhart W, Lehmann W, et al. Langzeitergebnisse nach Anwendung einer porösen Hydroxylapatitkeramik (Endobon) zur operativen Versorgung von Tibiakopffrakturen. Unfallchirurg. 2002;105:128-133 (Pubitemid 36062308)
19. Peltola MJ, Aitasalo KMJ, SuonpääJTK, et al. In vivo model for frontal sinus and calvarian bone defect obliteration with bioactive glass S53P4 and hydroxyapatite. J Biomed Mater Res Appl Biomater. 2001;58:261-269 (Pubitemid 34274501)
20. Muschler G, Lane J, Dawson E. The biology of spinal fusion. In: Cotler J, Cotler H, eds. Spinal Fusion, Science and Technique. Berlin Heidelberg New York: Springer; 1990
21. Leppäranta O, Vaahtio M, Peltola T, et al. Antibacterial effect of bioactive glasses on clinically important anaerobic bacteria in vitro. J Mater Sci: Mater Med. 2008;19:547-51 (Pubitemid 351236756)
22. Munukka E, Leppäranta O, Korkeamäki M, et al. Bactericidal effects of bioactive glasses on clinically important aero-bic bacteria. J Mater Sci: Mater Med. 2008;19:27-32
23. Lindfors NC, Hyvönen P, Nyyssönen M, et al. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis. Bone. 2010;47:212-218.